Teva Pharmaceutical Industries Ltd. (TEVA)

7.50
0.27 3.47
NYSE : Health Technology
Prev Close 7.77
Open 7.66
Day Low/High 7.41 / 7.88
52 Wk Low/High 6.07 / 23.97
Volume 20.38M
Avg Volume 20.58M
Exchange NYSE
Shares Outstanding 1.09B
Market Cap 7.77B
EPS -2.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Netflix, Bank of America, Opioid Settlement, Brexit, MGM- 5 Things You Must Know

Netflix, Bank of America, Opioid Settlement, Brexit, MGM- 5 Things You Must Know

U.S. stock futures decline as Wall Street awaits another round of third-quarter earnings reports and global stocks trade mixed as investors monitored Brexit developments; Netflix, IBM and Bank of America report earnings Wednesday; McKesson, AmerisourceBergen and Cardinal Health reportedly are in talks to pay $18 billion to settle thousands of opioid-related lawsuits.

Market on the Move: Cramer's 'Mad Money' Recap (Friday 10/11/19)

Market on the Move: Cramer's 'Mad Money' Recap (Friday 10/11/19)

Jim Cramer says the market is happy to hear about a possible trade agreement, but without details, it's hard to maintain momentum. Here's your game plan for next week.

Lifshitz & Miller LLP Announces Investigation Of Allegiant Travel Company, AMC Entertainment Holdings, Inc., Aqua Metals, Inc., CenturyLink, Inc., IVERIC Bio, Inc., And Teva Pharmaceutical Industries Ltd.

Lifshitz & Miller LLP Announces Investigation Of Allegiant Travel Company, AMC Entertainment Holdings, Inc., Aqua Metals, Inc., CenturyLink, Inc., IVERIC Bio, Inc., And Teva Pharmaceutical Industries Ltd.

NEW YORK, Oct. 13, 2019 /PRNewswire/ -- Allegiant Travel Company (ALGT) Lifshitz & Miller announces investigation into possible securities laws in connection with a CBS News 60 Minutes segment criticizing Allegiant's safety and maintenance records.

MGM Resorts, Teradyne, Boot Barn: 'Mad Money' Lightning Round

MGM Resorts, Teradyne, Boot Barn: 'Mad Money' Lightning Round

Jim Cramer takes a look at Teradyne, MGM Resorts, Boot Barn, and Teva Pharmaceuticals.

Teva To Host Conference Call To Discuss Third Quarter 2019 Financial Results At 8 A.m. ET On November 7, 2019

Teva To Host Conference Call To Discuss Third Quarter 2019 Financial Results At 8 A.m. ET On November 7, 2019

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its third quarter 2019 financial results on Thursday, November 7, 2019 at 7:00 a.

Teva To Present New Data On AUSTEDO® (deutetrabenazine) Tablets At Psych Congress 2019

Teva To Present New Data On AUSTEDO® (deutetrabenazine) Tablets At Psych Congress 2019

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that new AUSTEDO ® (deutetrabenazine) data will be presented at the 32 nd annual Psych Congress, October 3-6, 2019 in San Diego, California.

Eric Drapé, Executive Vice President, Global Operations At Teva. Photo Credit: Reuven Kapuchinski (Photo: Business Wire)

Eric Drapé, Executive Vice President, Global Operations At Teva. Photo Credit: Reuven Kapuchinski (Photo: Business Wire)

Teva Pharmaceutical Industries (NYSE and TASE: TEVA) announced today the retirement of Dr.

Endo, Opioid Producers Said to Mull Unusual Lawsuit Settlement; Shares Rise

Endo, Opioid Producers Said to Mull Unusual Lawsuit Settlement; Shares Rise

The Wall Street Journal reports the companies are considering participating in the bankruptcy proceedings of Purdue Pharma.

Jim Cramer: Here's Why the Market's So Feckless and Reactive

Jim Cramer: Here's Why the Market's So Feckless and Reactive

So many companies -- like Netflix, Facebook and Johnson & Johnson -- are not trading on earnings per share, but on factors that are nearly impossible to quantify.

Alder Biopharmaceuticals Surges on Lundbeck Offer

Alder Biopharmaceuticals Surges on Lundbeck Offer

Alder Biopharmaceuticals surges after rival Danish drugmaker Lundbeck announces plans to acquire the company and its late-stage migraine drug eptinezumab in a deal worth up to $1.95 billion.

INTERCURE: CANNDOC Signs Strategic Distribution Agreement With S.L.E. Of TEVA Pharmaceuticals

INTERCURE: CANNDOC Signs Strategic Distribution Agreement With S.L.E. Of TEVA Pharmaceuticals

HERZLIYA, Israel, Sept. 13, 2019 /PRNewswire/ -- InterCure (TASE: INCR), announced that subsidiary Canndoc has entered into a strategic distribution agreement with Salomon, Levin, Elstein (S.

Teva Announces United States Department Of Commerce Appointment Of Brendan O'Grady To Investment Advisory Council

Teva Announces United States Department Of Commerce Appointment Of Brendan O'Grady To Investment Advisory Council

Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced that the U.

Teva To Present New Analyses Of Fremanezumab Efficacy And Safety In Adult Patients With Difficult-to-Treat Migraine At 19th Congress Of The International Headache Society

Teva To Present New Analyses Of Fremanezumab Efficacy And Safety In Adult Patients With Difficult-to-Treat Migraine At 19th Congress Of The International Headache Society

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Company will present more than 30 analyses on fremanezumab, at the 19 th Congress of the International Headache Society (IHC), taking place in Dublin, Ireland on September 5-8,...

These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis

These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis

No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.

Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared

Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared

Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.

Dow Futures, Johnson & Johnson, Boeing, Papa John's - 5 Things You Must Know

Dow Futures, Johnson & Johnson, Boeing, Papa John's - 5 Things You Must Know

U.S. stock futures rise modestly on Tuesday as investors are cautiously optimistic a trade deal between Washington and Beijing can be reached; Johnson & Johnson is found responsible for helping fuel the opioid crisis in Oklahome and is ordered to pay $572 million; Russian conglomerate Rostec confirms it filed a lawsuit in the United States to cancel its order for Boeing 737 MAX jets, a report says.

Union Pacific, Pfizer, Merck, AbbVie: 'Mad Money' Lightning Round

Union Pacific, Pfizer, Merck, AbbVie: 'Mad Money' Lightning Round

Jim Cramer takes a look at Union Pacific, Pfizer, Merck, AbbVie, Teva Pharmaceuticals, ABM Industries, Schlumberger and more.

Hear Now the News (and Updates) on 2 Key Positions

Antares Pharma and Encana are on our radar today.

Teva Rises on Positive Test Results for Migraine Treatment

Teva Rises on Positive Test Results for Migraine Treatment

Teva says patients taking Ajovy experienced a significant reduction in migraine days compared to those receiving placebos.

Fremanezumab Data In The Lancet Demonstrate Clinically Meaningful Reduction In Monthly Migraine Days Versus Placebo For Patients With Difficult-To-Treat Migraine

Fremanezumab Data In The Lancet Demonstrate Clinically Meaningful Reduction In Monthly Migraine Days Versus Placebo For Patients With Difficult-To-Treat Migraine

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that results from the Phase IIIb FOCUS study, which examined fremanezumab versus placebo in adult migraine patients who previously experienced inadequate responses to two to four...

Endo Surges as Opioid Maker Reaches Settlement in Landmark Lawsuit

Endo Surges as Opioid Maker Reaches Settlement in Landmark Lawsuit

Endo's stock price surges after the company announces a settlement with Cuyahoga and Summit counties, removing the company from a potentially damaging trial in state court in October.

SHAREHOLDER ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Alerts Stockholders Of Class Action And Lead Plaintiff Deadline: August 20, 2019

SHAREHOLDER ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Alerts Stockholders Of Class Action And Lead Plaintiff Deadline: August 20, 2019

NEW YORK, Aug. 20, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Teva Pharmaceutical Industries Ltd.

Teva's Generic EpiPen Jr Is Now Available for $300

Teva's Generic EpiPen Jr Is Now Available for $300

There has been an EpiPen shortage in the U.S., Europe and Canada, thanks to manufacturing delays at Pfizer.

Teva Announces Availability Of A Generic Equivalent Of EpiPen Jr® (epinephrine Injection, USP) Auto-Injector, 0.15 Mg In The United States

Teva Announces Availability Of A Generic Equivalent Of EpiPen Jr® (epinephrine Injection, USP) Auto-Injector, 0.15 Mg In The United States

Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced availability of the FDA-approved generic version of EpiPen Jr® 1 (epinephrine injection, USP) Auto-Injector, 0.

Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids - Report

Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids - Report

Allergan is said to be discussing paying $5 million while Endo is close to an agreement to pay $10 million, according to a report.

How to Extract Pretty Profits from Ugly Stocks

How to Extract Pretty Profits from Ugly Stocks

It's a process that involves harvesting gains by repeatedly writing call options against stocks steadily in decline.

Stocks Finish Mixed in Volatile Trading Day

Stocks Finish Mixed in Volatile Trading Day

Stocks fell sharply before ending mixed Wednesday, as investors grappled with the U.S.-China trade war.

TheStreet Quant Rating: D (Sell)